{
  "company_number": "10469714",
  "name": "Carocell Bio Limited",
  "url": "/company/10469714",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2016-11-08",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "72110",
      "description": "Research and experimental development on biotechnology",
      "section": "M",
      "section_name": "Professional, scientific and technical activities",
      "url": "/sic/72110"
    },
    {
      "code": "75000",
      "description": "Veterinary activities",
      "section": "M",
      "section_name": "Professional, scientific and technical activities",
      "url": "/sic/75000"
    },
    {
      "code": "86900",
      "description": "Other human health activities",
      "section": "Q",
      "section_name": "Human health and social work activities",
      "url": "/sic/86900"
    }
  ],
  "registered_address": {
    "id": 1600621,
    "url": "/address/1600621",
    "line1": "LONDON BIOSCIENCE INNOVATION CENTRE (LBIC)",
    "line2": "2 ROYAL COLLEGE STREET",
    "post_town": "LONDON",
    "county": "",
    "country": "ENGLAND",
    "postcode": "NW1 0NH"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10469714",
  "previous_names": [
    {
      "name": "Bridge Biotec Limited",
      "ceased_on": "2019-08-14"
    },
    {
      "name": "Bridge Biotec Therapeutics Limited",
      "ceased_on": "2017-02-20"
    },
    {
      "name": "Bridge Biotech Therapeutics Limited",
      "ceased_on": "2016-11-15"
    }
  ],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2026-08-31",
    "last_made_up": "2024-11-30",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/10469714/accounts/2024-11-30",
        "made_up_date": "2024-11-30",
        "period_start": "2024-11-30",
        "period_end": "2024-11-30",
        "entity_name": "Carocell Bio Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "18635.00",
        "debtors": "8212.00",
        "cash_bank_in_hand": "854.00",
        "current_assets": "9066.00",
        "creditors_due_within_one_year": "13519.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-4453.00",
        "total_assets_less_current_liabilities": "14182.00",
        "net_assets_liabilities": "-367205.00",
        "called_up_share_capital": "1234.00",
        "profit_loss_account_reserve": "-1183334.00",
        "shareholder_funds": "-367205.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2025.zip"
      },
      {
        "url": "/company/10469714/accounts/2023-11-30",
        "made_up_date": "2023-11-30",
        "period_start": "2023-11-30",
        "period_end": "2023-11-30",
        "entity_name": "Carocell Bio Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "14885.00",
        "debtors": "6882.00",
        "cash_bank_in_hand": "6930.00",
        "current_assets": "13812.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "4852.00",
        "total_assets_less_current_liabilities": "19737.00",
        "net_assets_liabilities": "-340232.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1215.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2024.zip"
      },
      {
        "url": "/company/10469714/accounts/2022-11-30",
        "made_up_date": "2022-11-30",
        "period_start": "2022-11-30",
        "period_end": "2022-11-30",
        "entity_name": "Carocell Bio Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "19728.00",
        "debtors": "133250.00",
        "cash_bank_in_hand": "74111.00",
        "current_assets": "207361.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "188319.00",
        "total_assets_less_current_liabilities": "208047.00",
        "net_assets_liabilities": "-130715.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1195.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2023.zip"
      },
      {
        "url": "/company/10469714/accounts/2021-11-30",
        "made_up_date": "2021-11-30",
        "period_start": "2021-11-30",
        "period_end": "2021-11-30",
        "entity_name": "Carocell Bio Limited",
        "dormant": false,
        "average_employees": "4.00",
        "tangible_fixed_assets": "19753.00",
        "debtors": "8620.00",
        "cash_bank_in_hand": "160875.00",
        "current_assets": "169495.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-53642.00",
        "total_assets_less_current_liabilities": "-33889.00",
        "net_assets_liabilities": "-103889.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1125.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-May2022.zip"
      },
      {
        "url": "/company/10469714/accounts/2020-11-30",
        "made_up_date": "2020-11-30",
        "period_start": "2020-11-30",
        "period_end": "2020-11-30",
        "entity_name": "Carocell Bio Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "20478.00",
        "debtors": "1687.00",
        "cash_bank_in_hand": "9027.00",
        "current_assets": "10714.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-188722.00",
        "total_assets_less_current_liabilities": "-168244.00",
        "net_assets_liabilities": "-260244.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1030.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-July2021.zip"
      },
      {
        "url": "/company/10469714/accounts/2019-11-30",
        "made_up_date": "2019-11-30",
        "period_start": "2019-11-30",
        "period_end": "2019-11-30",
        "entity_name": "Carocell Bio Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "23546.00",
        "debtors": "1223.00",
        "cash_bank_in_hand": "2778.00",
        "current_assets": "4001.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-181978.00",
        "total_assets_less_current_liabilities": "-158432.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1025.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2020.zip"
      },
      {
        "url": "/company/10469714/accounts/2018-11-30",
        "made_up_date": "2018-11-30",
        "period_start": "2018-11-30",
        "period_end": "2018-11-30",
        "entity_name": "Bridge Biotec Limited",
        "dormant": false,
        "average_employees": "2.00",
        "tangible_fixed_assets": "14028.00",
        "debtors": "1311.00",
        "cash_bank_in_hand": "8021.00",
        "current_assets": "9332.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-79290.00",
        "total_assets_less_current_liabilities": "-65262.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1020.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2019.zip"
      },
      {
        "url": "/company/10469714/accounts/2017-11-30",
        "made_up_date": "2017-11-30",
        "period_start": "2017-11-30",
        "period_end": "2017-11-30",
        "entity_name": "Bridge Biotec Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": null,
        "debtors": "5939.00",
        "cash_bank_in_hand": "5326.00",
        "current_assets": "11265.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-33255.00",
        "total_assets_less_current_liabilities": "-27302.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "10.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-July2018.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/10469714/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2026-11-21",
    "last_made_up": "2025-11-07"
  },
  "officers": [],
  "psc": [
    {
      "name": "Dr Michael John Davies",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/3343982",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent",
        "voting-rights-75-to-100-percent",
        "right-to-appoint-and-remove-directors",
        "right-to-appoint-and-remove-directors-as-trust",
        "right-to-appoint-and-remove-directors-as-firm"
      ],
      "notified_on": "2016-11-08",
      "ceased_on": "2018-07-04",
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    },
    {
      "name": "Dr Michael John Davies",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/3343982",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-50-to-75-percent",
        "ownership-of-shares-50-to-75-percent-as-firm",
        "voting-rights-50-to-75-percent",
        "voting-rights-50-to-75-percent-as-firm",
        "right-to-appoint-and-remove-directors",
        "right-to-appoint-and-remove-directors-as-trust",
        "right-to-appoint-and-remove-directors-as-firm",
        "significant-influence-or-control-as-trust",
        "significant-influence-or-control-as-firm"
      ],
      "notified_on": "2016-11-08",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-02T05:26:26.711035+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}